The Prevalence of Shiga toxin-producing Escherichia coli in Patients with Gastroenteritis and Sources of Infections in Iran: A Systematic Review Study Protocol
Journal of Pediatric Nephrology,
Vol. 4 No. 3 (2016),
22 December 2016
Hemolytic Uremic Syndrome (HUS) is a leading cause of acute kidney injury in infants and children. The majority of HUS in children is secondary to Shiga toxin induced Escherichia Coli (STEC). Many countries have a strategy to identify the source of infection and annually estimate the rate of this infection but there is no prevention strategy to identify this infection in Iran.
The aim of this study is to find the percentage of STEC identified in various samples, in addition to find the outcome of STEC infected patients in Iran.
We will search PubMed, EMBASE, Google Scholar, Google, OVID, SCOPUS, Web of Sciences, IranMedex, MagIran, and SID, dociran, PDFiran, ganj.irandoc, and all online university database for thesis, and abstract books of regional or international congresses between January 1985 and January 2016.
One author will do the search screen for potentially eligible studies and two authors independently assess whether the studies meet the inclusion criteria. Discrepancies between the two authors will be resolved through discussion and arbitration by a third author. Data from the selected studies shall be extracted using a data collection form. The methodological quality of studies will be assessed using the STORBE checklist and risk of bias assessment tool developed by Hoy et al for assessing risk of bias for epidemiological studies. We will use random effects models to assess inter-study heterogeneity. Dichotomous data will be analyzed using relative risk and continuous will be assessed with data mean differences, both with 95% CIs.
Keywords: Gastroenteritis; Humans; Iran; Prevalence; shiga Yoxin 2; shiga-Toxigenic Escherichia coli.
- Shiga Toxin 2
- Shiga-Toxigenic Escherichia coli
How to Cite
Trachtman H, Austin C, Lewinski M, Stahl RA. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol. 2012 ;8(11):658-69. doi: 10.1038/nrneph 2012.196.
Hooman N. Acute Kidney Injury in Iranian Children -What Do We Know About It? Part 2. J Ped. Nephrology 2014;2(3):98-103.
Otukesh H, Hoseini R, Hooman N, Chalian M, Chalian H, Tabarroki A. Prognosis of acute renal failure in children. Pediatr Nephrol. 2006 ;21(12):1873-8.
Majowicz SE, Scallan E, Jones-Bitton A, et al. Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis. Foodborne Pathog Dis. 2014;11(6):447-55.doi: 10.1089/fpd.2013.1704.
Otukesh H, Hoseini R, Golnari P, et al. Short-term and long-term outcome of hemolytic uremic syndrome in Iranian children. J Nephrol. 2008 ;21(5):694-703.
Ataei N, Kheradmand K, Madani A, et al. The Importance of some Prognostic Factors In Children with hemolytic Uremic Syndrome in Medical Center From 1982 To 2002. Tehran Univ Med J. 2004; 62 (11) :888-93.
Hooman N, Otukesh H, Delshad S, Farhood P. Surgical complications of hemolytic uremic syndrome: Single center experiences. J Indian Assoc Pediatr Surg 2007 [cited 2016 Jun 17];12:129-32. Available from: http://www.jiaps.com/text.asp?2007/12/3/129/34950.
Hooman N, Otoukesh H, Talachian E, Hallaji F, Mehrazma M. Common bile duct stone associated with hemolytic uremic syndrome. Arch Iran Med. 2007 ;10(3):401-3.
Vally H, Hall G, Dyda A, et al. Epidemiology of Shiga toxin producing Escherichia coli in Australia, 2000-2010. BMC Public Health 2012 12:63.
Rosin P, Niskanen T, Palm D, Struelens M, Takkinen J. Shiga toxin-producing Escherichia coli Experts of the European Union Food- and Waterborne Diseases and Zoonoses Network. Laboratory preparedness for detection and monitoring of Shiga toxin 2-producing Escherichia coli O104:H4 in Europe and response to the 2011 outbreak. Euro Surveill. 2013;18(25):pii=20508. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20508.
Hosseini S, Kalantar E, Hooman N, Dorgalaleh A, Hosseini -Shamsabadi R, Taregh B. Evaluation of complement regulatory components in patients with atypical hemolytic uremic syndrome. Centr Eur J Immunol 2014; 39 (1): 67-70.
Islam MZ, Musekiwa A, Islam K, et al. Regional Variation in the Prevalence of E. coli O157 in Cattle: A Meta-Analysis and Meta-Regression. PLoS ONE 2014; 9(4): e93299. doi:10.1371/journal. pone.0093299.
Mehrazma M, Hooman N, Otukesh H. Prognostic value of renal pathological findings in children with atypical hemolytic uremic syndrome. Iran J Kidney Dis. 2011 ;5(6):380-5.
Hooman N, Esfahani ST, Mohkam M, et al. The outcome of Iranian children on continuous ambulatory peritoneal dialysis: the first report of Iranian National Registry. Arch Iran Med. 2009 ;12(1):24-8.
Hooman N, Mansour Ghanaei R, Yaghoubi M, Nakhaie S. The prevalence of Shiga toxin-producing Escherichia coli in patients with gastroenteritis and sources of infections in Iran: systematic review and meta-analysis. PROSPERO 2016:CRD42016033019 Availablefromhttp://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016033019
- Abstract Viewed: 1080 times
- PDF Downloaded: 461 times